UMEKIR PHARMA currently exports to over 15 countries, which include North America, CIS, Latin America, Africa and South-East Asia. With over 300 International Product Registrations (still expanding), UMEKIR PHARMA is emerging as a potential pharmaceutical company across the globe.
Today, UMEKIR PHARMA is providing a ceaseless supply of the finest-quality finished formulations to markets in every corner of the world
Driven by innovation and speed to market we focus on delivering world-class generics at an affordable price. Our unwavering determination to achieve excellence leads us to new global benchmarks.
UMEKIR PHARMA has built a visible presence across all its markets in Africa and Asia. The company enjoys strong presence in the pharmaceutical markets of Cameroon, Senegal, Ivory Coast, Mali, Conakry, Togo, Benin, Tchad, Congo, Gabon , Ghana, RD Congo, Myanmar, Sri Lanka , Sri Lanka, Philippines etc.
A number of its products have gained recognition as a brand in Indian and in the above mentioned International markets. UMEKIR PHARMA is making significant investments to build capabilities in R & D services to enhance its visibility.
For UMEKIR PHARMA, International business has always remained an area of successful strategic business growth, and will remain so in the years to come.
As of today, the company operates in over 30 countries globally for Formulations. With approval of its finished Dosage facilities by the WHO GMP, UMEKIR PHARMA has made an impression by offering QUALITY GENERIC product to customers globally.
We are coming up with an R & D centre in Mumbai. The activity profile will include:
